Immunotherapy Charts New Course for Resectable NSCLC Treatment
Three cycles of neoadjuvant nivolumab plus chemotherapy improved long-term clinical outcomes in patients with resectable stage IB-IIIA NSCLC.
Source: medscape.com
From Checkmate News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from From Checkmate. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In From Checkmate Today - Breaking & Trending Today